Online / Physical Event

3rd World Congress on


Theme: Tuning the Rhythm of Cardiology

Event Date & Time

Event Location

Zurich, Switzerland

Brochure Program Abstract Registration ReaderBase Awards

20 Years Of Excellence in Scientific Events



Conference Speaker


Max Hospital

Conference Speaker


Nicklaus Childrens Hospital

Conference Speaker


King Abdullah bin Abdulaziz University Hospital
Saudi Arabia

Conference Speaker


Childrens Hospital of Philadelphia-University of Pennsylvania

Conference Speaker


University Hospital of South Manchester

Conference Speaker

Branko Furst

Albany Medical College

Conference Speaker


Heart Center Dortmund

Conference Speaker


Great Ormond Street Childrens Hospital

Conference Speaker


Asablanca-Hassan II University

Conference Speaker


Azerbaijan State Medical University

Conference Speaker


Medical University of South Carolina

Conference Speaker


University of Chicago Comer Children Hospital

Tracks & Key Topics

Heart 2023

About Conference


3rd World Congress on Heart welcomes you for this time in Zurich , Switzerland during April 24-25, 2023

Heart 2023 Conferences will be an examination of the newest successions in heart disease recovery and prevention and on new analysis of innovation within the field of cardiac specialty.

Discussions on new Cardiac technology advancement in the field of Heart diseaseCardiovascular diseaseStem cell research on heartCongestive heart failureCurrent practices in cardiovascular therapyIschemic heart disease and Silent ischemiaHeart disease management and more.

Cardiac symposiums are rejuvenating. It is inspirational and energizing opportunity to connect with the greater scientific community, where you get to know about new cardiac strategies to approach your research. To contemplate the bigger picture and establish collaborations. A good conference has the capacity to bring a scientist within you; Cardiology conferences are very helpful for learning about new areas and publications of cardiology.

Heart 2023 is going to be an International event; We tend to even have a global faculty who are leading specialists in the field of cardiology. Gain valuable awareness from these distinguished professionals from accomplished establishments.

Why to attend Heart 2023 ???

With individuals from all around the globe focused on getting some answers concerning cardiology, this is one opportunity where you can accomplish the greatest accumulation of personalities from the mending focuses, universities, bunch, etc. These Cardiology Conferences and European Cardiology Congress in 2022 will coordinate and dissolve information, meeting with frequent outline and potential investigators and get name affirmation at this 2-day event. Broadly acclaimed speakers, the most recent frameworks, methodologies, and the most current updates in cardiology field are indications of this conference. This World Cardiology CongressCardiology GatheringsCardiology events and Cardiology Meetings will help in building organization, B2B uniting amidst specialists and academicians. The objective of this meeting is to stimulate new ideas for treatment and analyze the current market for the future direction of cardiovascular drugs, devices, and diagnostics, with a greater prominence on newer products that will be beneficial across the spectrum of cardiology. Lectures will offer a comprehensive high-tech apprise of the clinical uses of various practices in the diagnosis, prognosis, and management of common heart diseases.

This Heart Conference will be a truly an international event; we expect to welcome healthcare professionals from over 100 countries.

Scope & Importance:

Heart 2023 and Cardiovascular Conferences will seam world-class educators, scientists, and cardiologists to converse diverse procedures for heart disorder remediation, Electrocardiography, Heart Failure, Nuclear Cardiology. 

Cardiology ConferencesCardiology Meetings are envisioned to deliver flexible information that will keep cooperative experts next to each other of the topics impacting the anticipation, discovery, and treatment of cardiovascular infection. The world is becoming gradually exposed to public health challenges and risks for heart diseases. This conference provides a unique prospect for academicians, educators & clinicians as well as for experts and scholars of higher education from across the globe to convey and share unique ideas on crucial matters and latest trends in the field of cardiology. Starting from prevention through optimal care and finally the targeted treatment modes & rehabilitation, the whole range of cardiovascular disease shall be presented with world-class faculty, researchers, and mentors as well as healthcare clinical professionals.

Highest accomplishments in Cardiology:

Cardiology is a specialty of inner medicinal managing issue of the heart is it human or creature. The field incorporates therapeutic analysis and treatment of intrinsic heart imperfections, coronary vein infection, valvular coronary illness, and electrophysiology. Cardiology is concerned with the typical usefulness of the heart and the deviation from a sound heart. Numerous issues include the heart itself, yet some are outside of the heart. The pronounced success in lowering cardiovascular humanity rates during the last decade of the 20th century is secondary to the extraordinary improvements made in the understanding of basic cardiovascular science and in the expansion of new diagnostic and therapeutic methods. The most significant cardiologic developments and discoveries of the last century are Electrocardiography; Preventive Cardiology and the Framingham Study; “lipid hypotheses” and Atherosclerosis; Coronary Care Units; Echocardiography; Thrombolytic therapy; Cardiac Catheterization and Coronary Angiography; Open-heart Surgery; Automatic Implantable Cardiac Defibrillators and Coronary Angioplasty.

Advertise Analysis: 

The World Heart Federation (WHF) joins 200 people navigating 100 countries in the fight against cardiovascular sickness Global Data inquire about predicts the general business division for CMD contraptions will reach $1.2 billion by 2017. The overall cardiovascular contraption industry is turning out to be rapidly and is said that an advancement of $15 billion is created utilizing 2010-2015 as indicated by BCC examine. Items fused into this business part are electrocardiograph watching outfit, which is set to see 4% improvement by 2017 to be worth over $410 million The overall cardiovascular device industry is turning out to be rapidly and gives suggestions that it will continue progressing and develop to reach over $97 billion by 2017, up from just about $85 billion in 2010. 

Target Audience: 


Track 1: Hypertension

High blood pressure or hypertension increases the risk of heart disease and stroke. Hypertension risk factors include obesity, drinking too much alcohol, smoking, and family history. Beta-blockers are a common treatment for hypertension. High blood pressure usually does not cause symptoms.  Long term high blood pressure is a main risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease.

Track 2: Cardiovascular diseases and Heart

Heart attacks and strokes are usually acute events and are mainly caused by a blockage that prevents blood from flowing to the heart or brain. The most common reason for this is a build-up of fatty deposits on the inner walls of the blood vessels that supply the heart or brain. Strokes can also be caused by bleeding from a blood vessel in the brain or from blood clots. The cause of heart attacks and strokes are usually the presence of a combination of risk factors, such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol, hypertension, diabetes and hyperlipidemia.

Track 3: Interventional Cardiology

Interventional cardiology is a branch of cardiology that deals specifically with the catheter-based treatment of structural heart diseases. Interventional cardiology is a non-surgical option which uses a catheter – a small, flexible tube – to repair damaged or weakened vessels, narrowed arteries, or other affected parts of the heart structure.  A large number of procedures can be performed on the heart by catheterization. The main advantages of using the interventional cardiology or radiology approach are the avoidance of the scars and pain, and long post-operative recovery. Additionally, interventional cardiology procedure of primary angioplasty is now the gold standard of care for an acute myocardial infarction.

Track 4: Cardiovascular toxicology and Pharmacology

Cardiovascular toxicology deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It describes safety data of detrimental effects of new cardiovascular drugs. Cardiovascular pharmacology manages the drug of heart illnesses. Cardiac drugs are utilized to treat states of the heart or the circulatory or vascular framework. Many classes of cardiovascular operators are accessible to treat the different cardiovascular conditions. Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

Track 5: Cardiac surgery and Transplantation

Coronary artery bypass grafting (CABG) is the most usual type of heart surgery. CABG boosts blood flow to the heart. Surgeons make use of CABG to treat people who have critical Coronary Heart Disease (CHD).  For the heart to work well, blood should flow in only one direction. The heart's valves help to make this possible. Healthy valves open and close in a specific way as the heart pumps blood. Each valve has one set of flaps called leaflets. The leaflets open to allow blood to pass from one heart apartment into another or into the arteries. Then the leaflets close tightly to cease blood from flowing backward. Heart surgery is applied to fix leaflets that do not open as wide as they should. This can happen if they become thick or stiff or join. As a result, not enough blood flows through the valve. This Heart Congress scientific program has been CME and CPD certified.

Track 6: Structural heart disease interventions

Structural heart diseases are structural defects in the heart which may be present from the initial stages of birth, which need to be rectified by surgical interventions. Transcatheter techniques applied for treating non-coronary heart diseases are known as structural heart interventions. New opportunities continue to unfold in the field of treating structural heart interventions. The Present day structural heart intervention training programs include both valvular and non-valvular techniques concentrating on a wide range of adult primary congenital heart defects and complex surgical residual defects infant population. Many cardiologists prefer a new branch of percutaneous treatment which targets congenital and acquired diseases that were not addressed or were treated in another complex manner. Percutaneous structural heart interventions require a multi-axle approach involving cardiac imaging specialistsclinical cardiologistsinterventional cardiologistspediatricians and expert cardiac surgeons. A thorough assessment on patient procure compatibility must be made. Continuous enhancement of knowledge and training in materials and devices to be used individual specific procedures is a prerequisite. The catheterization lab in the hospital must be equipped to perform hybrid procedures.The following structural conditions are grouped together.

Track 7: Heart disease in women

Heart disease is a killer that strikes women than men and is more deadly. Women of all ages can be affected with heart disease. For younger women, the combination of smoking boosts and birth control pills, heart disease risks by 20 percent. In women risk increases with age, certain things like sedentary lifestyle and overeating can cause accumulation of plaque which leads to clogged arteries later.

Track 8: Current research in Cardiology
Track 9: Complications of Heart disease
Track 10: Cardiovascular Pharmacology

Pharmacology of vascular endothelium deals with modifications of endothelial cells and the vasculature play a crucial part in the pathogenesis of a wide range of the most dreadful of human diseases, as endothelial cells have the vital role of participating in the maintenance of patent and functional capillaries.

Track 11: Cardiology - future medicine

Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients’ expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modelling and information management issues. We also take a new approach to the way information is structured and delivered, so that its value is maximized to the reader. Accessible 'at-a-glance' formats are important in an increasingly time-constrained clinical community. Topics include the following areas:

Track 12: Clinical Cardiology

This session plays a significant role in the future of cardiology research. Cardiology concerns with diseases and disorders of the heart, such as coronary artery disease and congestive heart failure. The clinical cardiology includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, vascular heart disease and electrophysiology.

Track 13: Clinical case reports on cardiology

Cardiology case reports give an appropriate assemblage for all cardiologists by rendering their important clinical cases of late occurrence. Studying from medical cases provides valuable experience for clinicians, students and paramedical staff -members. Rare medical reports and conditions discovered through the latest methods of examination are reinforced. Furthermore, studying diagnostic methods from medical cases and interpretation of symptoms is significant to train and increase the processes which are being used in the clinical field.

Track 14: Diabetes & Heart

The term "Diabetic Heart Disease" (DHD) means heart disease that occurs in people who have high content of carbohydrate in blood. In comparison with people who don't have diabetes, people who have diabetes; are at a higher risk of heart disease, have additional reasons of heart disease, may develop heart disease at a younger age, may have more severe heart diseases. In Congenital Heart Disease, a waxy substance called plaque builds up inside the coronary arteries. These arteries supply our heart muscle with blood rich in oxygen. Plaque constitutes of fat, cholesterol, calcium, and various other substances found in the blood. When plaque happens in the arteries, the condition is called atherosclerosis. This Heart Conference scientific program has been CME and CPD certified.

Track 15: New directions in Cardiovascular surgery

The future holds dramatic advances that will transform the cardiac surgeon, in part, into an intervention list with new skills in diagnostic and therapeutic approaches to structural heart disease. The cardiovascular surgery has achieved great progress both on scale and technology though development over the past thirty years. However, the technical predominance of cardiovascular surgery in therapies for some diseases has been weakened, along with developments of new drugs and interventional technology. Currently, cardiovascular surgeons should practice the "patient first" principle, carry out individual customized treatment and precision therapy, absorb the advantages of other subjects like intervention and imaging in order to achieve technological breakthroughs, create new treatment technologies and models with smaller trauma and better outcome, establish heart team to provide patient oriented treatment. Besides, cardiovascular surgeons should improve knowledge system by learning related technology and science, become hybrid Doctor of Research. Cardiovascular surgeons should pay high attention to critical effect of research on the disciplinary development, change the medical practice by virtue of research achievements, direct the treatment for cardiovascular diseases, and finally provide better health service and rebuild the predominance of cardiovascular surgery.

Track 16: Electrocardiography

Electrocardiography (ECG) is the method of recordance of the electrical activity of the heart over a time period using electrodes placed on the skin. These electrodes help in the detection of the minute electrical changes on the skin that arise from the electrophysiologic pattern of heart muscle while depolarizing during each heartbeat. This record called the electrocardiogram (also known as an ECG), gives information about the part of the heart that triggers each heartbeat (the pacemaker called the Sino-atrial node), the nerve conduction pathways of the heart, and the heart rate and rhythm . Usually, an ECG is obtained if a heart disorder is suspected. This Heart Congress scientific program has been CME and CPD certified.

Track 17: Cardiac and Cardiovascular research

Cardiovascular research is to learn the basic, translational, and clinical research of cardiovascular diseases. Cardiovascular diseases, including Heart Rhythm and Arrhythmias, HIV and Heart Disease, Imaging, Interventional Cardiology, Myocardial Biology/Heart Failure, Preventive Cardiology, Women and Heart Disease, congestive heart failure, hypertension, atherosclerosis, stroke, aneurysms, and vascular auto-immune diseases are the most common cause of death and disability in the United States, and account for approximately 30% of deaths and health care costs annually in this country and developed societies. The mission of Cardiovascular Research is to support interdisciplinary research in basic, translational and clinical cardiovascular sciences, including cardiovascular development, function, pathophysiology, pharmacology, genetics, genomics, and proteomics, and to apply this knowledge to better understand the causes of cardiovascular diseases and to pioneer development of new innovative therapies and approaches to prevent or treat them.

Track 18: Advances in Cardiovascular imaging

Advanced Cardiac imaging, using cardiac magnetic resonance imaging (MRI) and multi detector computed tomography (CT), is increasingly used in the work-up of athletes with suspected abnormalities on screening. Both imaging modalities produce highly accurate and reproducible structural and functional cardiac information. Cardiac MRI has the advantage of imaging without radiation exposure or the use of iodine-containing contrast agents but is sometimes not possible due to claustrophobia or other contraindications. Although cardiac MRI can rule out coronary artery anomalies, multi detector CT is superior to cardiac MRI for visualizing the full extent of the coronary arteries and atherosclerotic coronary artery disease. Echocardiography remains the most advanced tool for noninvasive cardiac imaging because of its applicability for most cardiac disorders and its exquisite spatial resolution. 

Track 19: Vascular Biology

The Vascular Biology exists as a wide-ranging discipline that includes study of vascular function, structure, growth as well as development.  This field comprises investigation at essentially all levels, including studies of molecules, cells, organs also intact organisms.  Perturbations of vascular function be there involved in various pathophysiological states, with neoplasia, inflammation, aging, neurological diseases, metabolic disorders pulmonary diseases also hypertension.

Track 20: Cardiac diagnosis test

The diagnostic tests are used for identifying the heart function & heart conditions associated with healthy vs. unhealthy individuals in cardiology. Cardiac stress testing is used to assess the cardiac function and to disclose the evidence of cardiac hypoxia. In the areas of perfusion abnormalities, thallium 0r technetium can be used through Radionuclide test. With a maximal stress test, the level of exercise gets increases until the person's heart rate will not increase highly. Coronary catheterization, echocardiogram, intravascular ultrasound, and the coronary calcium scan are given as the cardiac imaging techniques which can be used in cardiac diagnosis.


Heart - 2023 wants to join scientists, teachers & cardiologists to discuss methodology for remediation for heart, Electrocardiography, Nuclear Cardiology, and Heart Failure. Cardiology meetings, Cardiology conferences organized to give changing and stream preparing that will keep helpful specialists next to each other of the issues impacting the expectation, finding and treatment of cardiovascular contamination.

Join us at Zurich, Switzerland on April 24-25 in the next year 2023 so that we can indulge into the interesting and exciting attractions of the beautiful city of Zurich……

Cardiology is a branch of medicine dealing with disorders of the heart; be it human or animal. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology. Physicians who specialize in this field of medicine are called Cardiologists, a specialty of internal medicine.

A prospective survey of patients with valvular heart disease (VHD):

  • Coronary angiography was used in 85.2% of patients before intervention.
  • The Euro Heart Survey (EHS) program has been initiated order to provide quantitative information on cardiovascular disease.
  • To prevent the incidence of cardiovascular (CV) disease, by implementing strategies to reduce the burden of CV risk factors and incidence of CV disease and develop appropriate models for healthy CV lifestyle.

With members from around the world focused on learning about Cardiology, this is your single best opportunity to reach the largest assemblage of participants from the hospitals, Universities, community, etc. This Annual Meeting will conduct demonstrations, distribute information, meet with current and potential researchers and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Cardiology field are hallmarks of this conference.

The Global Stroke Diagnostics and Therapeutics market is accounted for $23,849.39 Million in 2017 and is relied upon to reach $49,698.68 Million by 2026. The worldwide interventional cardiology devices market has been relied upon to get a handle on $25.16 billion by 2020. Cardiovascular illness is the significant reason for deaths affecting lives everywhere throughout the world. These maladies are essentially related with heart and blood vessels disorders, for example, ischemic coronary illness, stroke, dyslipidemia, thrombosis, atherosclerosis, coronary artery diseases, hypertension and others. These conditions are reported because of obesity, elevated cholesterol, unfortunate dietary propensities, absence of physical activity, smoking, unnecessary liquor, and poor way of lifestyle. Europe was the second greatest territory in 2014, with rising occurrences of obesity and changing lifestyle habits and advancing number of smokers oversee the incident of cardiovascular disease prevalence. The interest for anti-hypertensive medications is feasible and will increase with an expansion in the number of target patients.


The cardiovascular market research reports by iData cover Interventional Cardiology, Cardiac Rhythm Management, Cardiac Surgery and the Electrophysiology market. The wildest growing segments within interventional cardiology are expected to be driven by new technologies, such as CTO crossers, FFR guidewires and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices.

Covid19 Impact on the Global Interventional Cardiology Market

In 2020, the global interventional cardiology market size was treasured at approximately $11.1 billion, down from nearly $14 billion in 2019 due to the impact of COVID-19. The global market size is expected to reach an astonishing $16.2 billion in 2027. This global market research includes an analysis of 46 interventional cardiology companies laying across more than 70 countries in the world.

Due to COVID19, the global interventional cardiology market size reduced by 20% from 2019, reaching a valuation of $11.1 billion in 2020. The global market is expected to recover in early 2022 and continue growing at a steady pace.

The WHO confirmed COVID-19 as a pandemic in March 2020. Meanwhile then, millions of patients around the world had their care late as hospitals canceled non-urgent operations, including some surgeries for people with heart and lung conditions. As a result, every region around the world has experienced record low numbers for angiographies and angioplasties in 2020.

Global Interventional Cardiology Market Insights

Global technologies, such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and preventive the total number of diagnostic procedures completed.

Access to healthcare and overall hospital infrastructure in developing countries within Latin America and the Asia Pacific, such as China and India, have been increasing over the last decade. In Brazil, for example, healthcare access in the most remote and poorest areas of the country has been dramatically improved through their Family Health Program (PSF) initiative. Since this program launched in 1994, states in Brazil were required to allocate a minimum of 12% of the total budget to health, while municipal governments must spend 15% of their budget on health.

Increasing Coronary Artery Diseases Driving the Growth of the Interventional Cardiology Devices Market Worldwide

The rising number of coronary artery diseases drives the growth of the global interventional cardiology devices market. According to the Center for Disease Control and Prevention (CDC), roughly 18.2 million adults were grief from coronary artery diseases in the U.S. in 2017. Among every ten deaths, two deaths are happening because of coronary artery diseases. High cholesterol levels and high stress also act as major risk factors for developing coronary heart diseases. Moreover, the market for interventional cardiology devices is increasing due to an increase in diabetes and hypertension, which are major causes of coronary artery disease.

Impact of COVID-19 on the Global Interventional Cardiology Devices Market

Globally, COVID outbreaks are leading to major health disasters. The governments of different nations have been taking various measures like lockdowns, hand sanitization, and travel restrictions to prevent the infection of coronaviruses. To minimize the risk of disclosure to patients and staff, hospitals are embracing online and video consultation in compliance with NHS guidelines. As patients are scared to visit hospitals in the fear of contracting the virus, various cardiovascular measures were also reduced, including computed tomography, coronary angiography (CTCA), and dobutamine stress echocardiograms (DSE).In addition, the lockdown and travel restrictions prevent patients from reaching the hospitals, which in turn is negatively impacting the interventional cardiology devices market. Moreover, the number of casualties is decreasing, which affects the market. Corona burst has led to patients be afraid of that if they have surgery, they will get COVID, thus reducing the number of surgeries that are performed, which leads to a failure in the demand for interventional cardiology devices. These factors negatively impact the growth of the interventional cardiology devices market.


Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!